STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
MBRX MOLECULIN BIOTECH INCORPORATED StockScouter® Report
4
StockScouter® Score
MOLECULIN BIOTECH INCORPORATED, a micro cap company in the healthcare sector, is expected to underperform the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
Concerns
- The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
- Moving average analysis for MBRX suggests weak price movement over the medium term. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be out of favor, stocks will be , and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
F
N/A
N/A
D